Clinical Trials / Belgium: Punching Well Above its Weight
Despite a population size of only 11.4 million (ninth in Europe), Belgium is the continent’s fifth biggest…
EUROPE
The Long Read / Sweden: An Innovation Nation
Sweden’s USD 4.8 billion pharmaceutical market, its population size of 10 million and marginal positioning on the…
Internationalization / Chiesi Moves into Rare Diseases & the US Market
Italian mid-cap firm Chiesi is continuing its expansion in the USA market with the launch of a Boston-based…
Belgium Pharma Market Snapshot
The Belgian retail market continues to grow in value, while decreasing slightly in volume, to reach a total of EUR…
Medtech / A Vital Sector in the Czech Republic
Key stakeholders within the Czech medtech industry highlight how medical devices can improve efficiency and quality…
CEE / Romania's Vaccination Crisis: Small Steps Forward
Quite unfortunately, Romania has some of the highest infant mortality and maternal mortality rates in Europe, and…
Clinical Trials / Finding the Niches in the Czech Republic
The Czech Republic boasts a solid clinical research infrastructure and a supportive regulatory environment, meaning…
Orphan Drugs / Building the Regulatory Framework in the Czech Republic
A cross-industry push for better and broader access to innovative treatments is underway in the Czech Republic.…
Romania Pharma Market Snapshot 2019
Market overview with data on growth areas, key therapeutic areas, generics/originators split and more. Made with…
In Conversation
Pál Szamosújvári – Founder, Pál Szamosújvári Jr – Director, & Judit Jávor – R&D Director, Pharma Patent, Hungary
MD Pál Szamosújvari, Judit Jávor, Pál Szamosújvari Jr—Founder, R&D Director, and Director of Pharma Patent respectively—share their insights on the activities of the company, the importance of R&D, the challenges of smaller companies, its marketing strategy of its niche products, and its internationalization strategy. Can you introduce yourself and the activities of Pharma Patent? Judit Jávor: I am a…
Latest Reports
Focus on Spain
New Spain Pharma Report September 2019 Out Now
Building on the topics covered in our March 2019 report, the latest edition of…
Jazz Pharmaceuticals Spain: Playing to a Different Beat
Though still one of the younger and lesser-known outfits inhabiting the European…
Read more from Spain >>
Focus on Switzerland
Merck’s EUR 250 Million Investment in New Swiss Biotech…
German biopharma giant Merck is investing EUR 250 million in a new Swiss biotech…
Outsourced Manufacturing: A Swiss Specialty
Unknown to some, Switzerland meanwhile remains both influential and relevant in…
Read more from Switzerland >>
Focus on Sweden
Sweden: An Innovation Nation
Sweden’s USD 4.8 billion pharmaceutical market, its population size of 10…
New Sweden Pharma Report December 2019 Out Now
Belying its small size, the Nordic nation of Sweden punches well above its…
Read more from Sweden >>
Focus on France
France’s Institut Pasteur Isolates Coronavirus; On Course…
Researchers at the Institut Pasteur in Paris have become the first in Europe to…
Problems Pile Up at Ipsen after Further Clinical Setback
These are worrying times for iconic French mid-cap Ipsen. Trials for…
Read more from France >>
Company Spotlight / STADA Czech Republic
As one of the few pharma companies in the Czech Republic to offer products across the whole healthcare spectrum,…
Company Spotlight / Egis: Holding On To Hungarian Heritage
Established in Hungary in 1913, Egis is a traditional Central Eastern European pharmaceutical company with an…
CEO Profile / Jean-Christophe Tellier, UCB
Jean-Christophe Tellier became UCB’s CEO on January 1, 2015 only a few years joining the company in 2011. Before…
FarmaMondo: Bringing Responsible Access Global
With two billion people globally – predominantly in low and middle-income countries – having little or…
Merck Announces EUR 1 Billion HQ Investment
German giant Merck KGaA has announced a EUR one billion investment into its headquarters in Darmstadt, Germany up…
Orphan Drugs / Building the Regulatory Framework in the Czech Republic
A cross-industry push for better and broader access to innovative treatments is underway in the Czech Republic.…